Actos ads call for Avandia switch

Share this article:
Takeda ran newspaper ads urging readers to switch to its Actos from rival Avandia after the GlaxoSmithKline drug was hit with FDA marketing restrictions due to safety concerns. The ad, which ran for two weeks in Septmeber and October, bore the headline: “Are you taking Avandia and considering a change?”

The campaign, by AbelsonTaylor and Ketchum, ran in 90 markets and 121 papers, advising patients to “Ask if Actos is right for you” and proffering a 1-800 number and free 30-day trial.

Amid worries about heart risks, FDA decided to keep the drug on the market but with additional restrictions.
An Actos print campaign earlier this year stuck to the science, leveraging Actos' safety profile and stressing that Avandia's safety issues are not a class effect.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?